| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,282 |
1,820 |
$219K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,673 |
2,178 |
$172K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,510 |
2,294 |
$87K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
584 |
556 |
$55K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
505 |
472 |
$48K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
520 |
465 |
$44K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
273 |
221 |
$32K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,577 |
1,485 |
$27K |
| 96127 |
|
1,143 |
973 |
$19K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
167 |
157 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
444 |
264 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
170 |
142 |
$8K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
150 |
136 |
$6K |
| 90461 |
|
911 |
857 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
308 |
274 |
$5K |
| 90651 |
|
66 |
58 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
65 |
56 |
$3K |
| 90688 |
|
432 |
409 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
72 |
55 |
$2K |
| 90480 |
|
52 |
33 |
$2K |
| 90473 |
|
115 |
103 |
$2K |
| 99173 |
|
188 |
182 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
132 |
103 |
$1K |
| 90670 |
|
125 |
117 |
$1K |
| 90672 |
|
165 |
155 |
$947.41 |
| 99460 |
|
12 |
12 |
$913.00 |
| 87807 |
|
79 |
75 |
$855.77 |
| 90686 |
|
369 |
315 |
$790.26 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$755.07 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
72 |
67 |
$696.70 |
| 90698 |
|
152 |
144 |
$661.50 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
12 |
12 |
$617.76 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
13 |
13 |
$367.32 |
| 90660 |
|
34 |
33 |
$242.97 |
| 36415 |
Collection of venous blood by venipuncture |
41 |
36 |
$199.48 |
| 94760 |
|
41 |
37 |
$81.18 |
| 96160 |
|
80 |
74 |
$77.23 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
15 |
$74.65 |
| 99000 |
|
14 |
13 |
$38.87 |
| 90687 |
|
28 |
27 |
$19.80 |
| 90680 |
|
12 |
12 |
$0.00 |
| 91321 |
|
26 |
15 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |